SCHEMBL28049063

SCHEMBL28049063

CCS(=O)(=O)Oc1c(-c2ccc(Cl)cc2)csc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.40
PRKCZ Q05513 1/20 0.38
PTGS2 P35354 3/20 0.34
KDM1A O60341 3/20 0.34
ANO1 Q5XXA6 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
XBP1 P17861 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
BCL2 P10415 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28049141 0.88 PTGS2 (0.45) PRKCZPTGS2GAAL3MBTL1PTGS1
SCHEMBL28049099 0.87 LMNA (0.35) FFAR4PRKCZPTGS2KDM4EALDH1A1
SCHEMBL28123376 0.86 PTGS2 (0.40) PTGS2KDM4EALDH1A1MEN1MAPT
SCHEMBL28123342 0.83 FFAR4 (0.37) FFAR4PRKCZPTGS2L3MBTL1PTGDR2
SCHEMBL28358513 0.81 PTGS2 (0.38) FFAR4PTGS2POLBGAAL3MBTL1
SCHEMBL28049060 0.79 FFAR4 (0.43) FFAR4PRKCZANO1KDM4EMAPT
SCHEMBL28354792 0.79 CYP2A6 (0.41) PTGS2PTGS1
SCHEMBL16048887 0.78 PRKCZ (0.45) PRKCZPTGS2ALDH1A1MAPTSMN1; SMN2
SCHEMBL28122721 0.77 FFAR4 (0.45) FFAR4MEN1POLBMAPTXBP1
SCHEMBL28354819 0.76 RAB9A (0.42) FFAR4PTGS2KDM4EMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106414434-A Isothiazole derivatives as gpr120 agonists for the treatment of type ii diabetes 詹森药业有限公司 2017-02-15 CN disclosed
CN-105209446-A GPR120 agonists for the treatment of type ii diabetes JANSSEN PHARMACEUTICA NV 2015-12-30 CN disclosed